News
PMA Final Decisions for June 2010
August 3, 2010 10:39 am | by U.S. Food & Drug Administration | CommentsThese are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for June 2010.
Boston Scientific begins adding patients in stent trial
August 3, 2010 10:39 am | by Mass High Tech: The Journal of New England Technology | CommentsNatick medical device giant Boston Scientific Corp. has begun enrolling patients in its EVOLVE clinical trial to test the safety of its Synergy coronary stent. The trial is expected to enroll 291 patients in 35 locations throughout Europe, Australia and New Zealand.
Curis begins trial of cancer treatment
August 3, 2010 10:39 am | by Mass High Tech: The Journal of New England Technology | CommentsCuris Inc. has treated its first patient in a Phase 1b expansion trial for its small molecule drug candidate, CUDC-101, intended to treat advanced head and neck, gastric, breast and liver cancers.
InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing
August 3, 2010 10:37 am | by Bio-Medicine.Org | CommentsHUNTSVILLE, Ala. and MARLBOROUGH, Mass. , Aug. 3 /- InQ Biosciences Corporation , a provider of innovative technologies for cell growth and research, announced the appointment of John Ryder as Senior Vice President, Sales and Marketing. Ryder will be based in InQ's sales office in...
Fujifilm Dimatix achieves a strong showing at Shanghai 2010 Ad, print and sign expo
August 3, 2010 8:37 am | by I-Micronews | CommentsFujifilm Dimatix products featured in 36 OEM printers ? 28 of which use new Spectra® Polaris Q-Class printheads. Asian launch of Fujifilm Dimatix DMP-3000 Material Printer and new D-Class printheads for materials deposition applications was enthusiastically received.
Acorda 2Q loss narrows on Ampyra sales
August 3, 2010 7:45 am | by The Associated Press | CommentsBiotechnology company Acorda Therapeutics Inc. said Tuesday its second-quarter loss narrowed on a boost in sales of the multiple sclerosis drug Ampyra.The company lost $6.8 million, or 18 cents per share, compared with a loss of $23.3 million, or 62 cents per share, during the same period a...
Mednax 2Q earnings climb 14 pct to $49.4 million
August 3, 2010 7:45 am | by The Associated Press | CommentsNational physician group Mednax Inc. said Tuesday its second-quarter earnings climbed 14 percent, as contributions from newly acquired doctor practices helped boost revenue.Mednax earned $49.4 million, or $1.04 per share, in the three months that ended June 30. That compares to earnings of...
Tenet turns 2Q profit on greater revenue per visit
August 3, 2010 7:45 am | by The Associated Press | CommentsHospital operator Tenet Healthcare Corp. on Tuesday reported a profit in the second quarter as it received more revenue per patient visit.Tenet posted net income of $25 million, or 5 cents per share. That compares with a loss of $15 million, or 3 cents per share, one year ago. Revenue rose 3...
Sun Healthcare Group offering 19.3 million shares
August 3, 2010 7:45 am | by The Associated Press | CommentsHealth care facility operator Sun Healthcare Group Inc. said Tuesday it is publicly offering 19.3 million shares of common stock.The company will also give underwriters a 30-day option to buy up to 2.9 million additional shares of stock to cover any overallotments. Sun said it would use the...
PerkinElmer acquires imaging tech firm VisEn Medical
August 3, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | CommentsPerkinElmer Inc., a Waltham provider of equipment and services to support human and environment health, has bought Bedford molecular imaging technology company VisEn Medical Inc.
AACR Hosts Molecular Diagnostics Conference in Denver, Colo.
August 3, 2010 7:34 am | by AACR | CommentsThis year, the American Association for Cancer Research will host its fourth Molecular Diagnostics in Cancer Therapeutic Development: Challenges and Horizons conference at the Sheraton Denver Downtown Hotel in Denver, Colo. This meeting regularly draws representatives from academia and...
Idera pulling in $15M financing
August 3, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | CommentsIdera Pharmaceuticals Inc. is raising $15 million in a registered direct offering the Cambridge biotech has made with investors.
Accuray's CyberKnife G4 System Receives Shonin Approval
August 3, 2010 6:35 am | by Bio-Medicine.Org | CommentsSUNNYVALE, Calif. , Aug. 3 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today it received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the CyberKnife® G4 Robotic Radiosurgery System to...
Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
August 3, 2010 6:34 am | by Bio-Medicine.Org | CommentsSAN DIEGO , Aug. 3 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) announced the online publication of results from its COR-BMOD trial of Contrave® (naltrexone SR/bupropion SR) in the journal Obesity . The COR-BMOD trial evaluated intensive behavior modification (BMOD) plus...
Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast
August 3, 2010 6:34 am | by Bio-Medicine.Org | CommentsSAN DIEGO , Aug. 3 /- Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the...
